Author

F. Can

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:clinical cohort / trial· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:metabolomics· 1 Organism:multiple species· 1

Frequent Co-Authors

O. Ergonul· 3 shared A. Al-Hakeem· 1 shared A. Ceylan· 1 shared A. Demiray· 1 shared A. G. Erman· 1 shared A. Hanifehnezhad· 1 shared A. Ozkul· 1 shared B. Gul· 1 shared

Activity by Year

2018-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

O. Ergonul

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

FABP4 as a Therapeutic Host Target Controlling SARS-CoV2 Infection

H. Baazim, E. Koyuncu, G. Tuncman, M. F. Burak, L. Merkel, N. Bahour, E. S. Karabulut, G. Y. Lee, A. Hanifehnezhad, Z. F. Karagoz, K. Foldes, I. Engin, A. G. Erman, S. Oztop, N. Filazi, , G. S. Hotamisligil

This study identifies FABP4 as a host target that modulates SARS-CoV-2 infection, showing that its inhibition reduces viral replication and lung damage in infected hamsters.

bioRxiv · Feb 10, 2024 · PreprintMicrobiology

The role of iron uptake systems in the pathogenesis of colistin-resistant hypervirulent K. pneumoniae infections

O. Dogan, C. Vatansever, N. Atac, O. Albayrak, S. Karahuseyinoglu, O. E. Sahin, B. K. Kilicoglu, A. Demiray, O. Ergonul, M. Gönen, F. Can

This study identifies iron uptake systems as critical for survival of hypervirulent colistin-resistant K. pneumoniae against neutrophils and suggests targeting these systems as a therapeutic strategy.

bioRxiv · Jun 21, 2019 · PreprintMicrobiology

Adaptation of Acinetobacter baumannii to colistin exposure: Laboratory mimicking of a clinical case

E. Oralkan, S. Keske, O. Ergonul, F. Can

The paper describes how Acinetobacter baumannii adapts to colistin exposure in a clinical case, showing that resistance develops after three weeks of treatment.

bioRxiv · Dec 19, 2018Microbiology